Attached files
| file | filename |
|---|---|
| EX-99 - EXHIBIT 99.1 - COGENTIX MEDICAL INC /DE/ | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 9, 2013
VISION-SCIENCES, INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
000-20970 |
|
13-3430173 |
|
(State or other jurisdiction |
|
(Registration Number) |
|
(IRS Employer |
|
of incorporation) |
|
Identification No.) |
|
Identification No.) |
|
40 Ramland Road South Orangeburg, NY |
|
10962 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (845) 365-0600
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 8.01 |
Other Events |
|
(b) |
On September 9, 2013, Vision-Sciences Inc.(the “Company”) issued a press release reporting positive results from a three-month evaluation completed in 2012 by the British Army at Camp Bastion, a deployed field hospital in Afghanistan.. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. |
|
ITEM 9.01 |
Financial Statements and Exhibits
|
|
(d) |
Exhibits |
|
99.1 |
Press release issued by the Company on September 9, 2013. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, Vision-Sciences, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
VISION-SCIENCES, INC. | ||
|
|
|
| |
|
|
|
| |
|
|
By: |
/s/ Howard Zauberman | |
|
|
|
Name: |
Howard Zauberman |
|
|
|
Title: |
Interim Chief Executive Officer |
Date: September 9, 2013
3